Oana Danciu, MD, explained why phase 1 breast cancer trials are moving earlier in the treatment course and how disease stability guides patient selection.
Oana Danciu, MD
Advertisement
Articles by Oana Danciu, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Which Head and Neck Cancer Data Should You Watch For at ESMO 2026?
2
Efficacy and Safety of Immune Checkpoint Inhibitors Combined With Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer
3
FDA Approves Pembrolizumab in Metastatic TMB-H Solid Tumors
4
Discussing Guidelines, New Data, and Earlier Referrals in Multiple Myeloma
5